Efficacy of XP20B Following Bunionectomy Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Acute Pain

In brief

The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.

Key facts

Study ID

NCT00655291

Run by

Xanodyne Pharmaceuticals

People needed

190

Starts

2008-04-01

Expected to finish

2008-08-01

Last updated by the study team

2008-10-08

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• having undergone bunionectomy surgery
• having achieved the requisite level of pain

You may not qualify if…

• pregnant or lactating
• history of substance abuse
• clinically significant condition or lab abnormality
• taken any prohibited medications
• gastrointestinal bleeding or history of

Where it is running

• Investigatve Site — Anaheim, California, United States
• Investigative Site — Owings Mills, Maryland, United States
• Investigative Site — Austin, Texas, United States
• Investigative Site — Houston, Texas, United States
• Investigative Site — San Marcos, Texas, United States
• Investigative Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.